It’s a DPP-4 inhibitor, a class with three other drugs in the U.S. The brand name in the U.S. is Nesina. It can be used with other drugs such as metformin and pioglitazone. The FDA’s press release of Jan. 25 has a little more info.
Comments Off on FDA Approves New T2 Diabetes Drug: Alogliptin
Filed under Uncategorized
Comments are closed.
RSS - Posts
Enter your email address to subscribe to this blog and receive notifications of new posts by email.
Join 584 other followers